Genmab A (GMAB) Operating Leases (2019 - 2025)

Genmab A's Operating Leases history runs 5 years deep, the most recent figure standing at $152.0 million for Q4 2025.

• Quarterly Operating Leases rose 16.03% year-over-year to $152.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $152.0 million (up 16.03% YoY) and the FY2025 annual result came in at $152.0 million, up 16.03% from the prior year.
• Operating Leases was $152.0 million for Q4 2025 at Genmab A, up from $143.0 million in the prior quarter.
• Across five years, Operating Leases topped out at $152.0 million in Q4 2025 and bottomed at $101.0 million in Q4 2023.
• A 3-year average of $131.8 million and a median of $137.0 million in 2024 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2024 — Operating Leases climbed 29.7% — and 2025, when it climbed 16.03%.
• Genmab A's Operating Leases stood at $101.0 million in 2023, then rose by 29.7% to $131.0 million in 2024, then gained by 16.03% to $152.0 million in 2025.
• Business Quant data shows GMAB's Operating Leases at $152.0 million in Q4 2025, $143.0 million in Q1 2025, and $131.0 million in Q4 2024.